Xiuning Le, Mike Hernandez, Simon Heeke, Andreas Saltos, John V. Heymach. "Reply to: Osimertinib Plus Antiangiogenic Agents: A Promising New Paradigm With Uncertain Results." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco-25-00032